Table 1 Study schedule
Study period | ||||||
|---|---|---|---|---|---|---|
Assessments | Time point | |||||
Enrolment Allocation | Baseline assessments | Intervention weekly for 12 weeks | Post intervention visit at 3months | Intervention weekly for 12 weeks | Visit at 6 months | |
Eligibility screen | * | |||||
Montreal cognitive assessment (MOCA) | * | |||||
Informed consent | * | |||||
Random allocation | * | |||||
Meditation intervention | *(meditation arm only) | *(waitlisted arm only) | ||||
Assessments | ||||||
Medical history/Interviewer administered data collection | * | |||||
Fasting blood sugar | * | *(monthly at clinic) | * | *(monthly at clinic) | * | |
HbA1c | * | * | * | |||
Fructosamine | * | * | * | |||
Fasting serum insulin | * | * | * | |||
Full blood count | * | |||||
Liver /renal functionsa | * | |||||
24-h urinary free cortisol | * | * | * | |||
Lipid profile | * | * | * | |||
Body mass index | * | * | ||||
Blood pressure | * | *(monthly at clinic) | * | *(monthly at clinic) | * | |
Autonomic function tests | * | * | * | |||
Oro-caecal transit time | * | * | * | |||